Logo image of LFMD

LIFEMD INC (LFMD) Stock Fundamental Analysis

USA - NASDAQ:LFMD - US53216B1044 - Common Stock

6.15 USD
-0.02 (-0.32%)
Last: 10/22/2025, 4:37:17 PM
6.15 USD
0 (0%)
After Hours: 10/22/2025, 4:37:17 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LFMD. LFMD was compared to 35 industry peers in the Health Care Technology industry. LFMD may be in some trouble as it scores bad on both profitability and health. LFMD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LFMD has reported negative net income.
In the past year LFMD had a positive cash flow from operations.
LFMD had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LFMD reported negative operating cash flow in multiple years.
LFMD Yearly Net Income VS EBIT VS OCF VS FCFLFMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M

1.2 Ratios

The Return On Assets of LFMD (-12.28%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -12.28%
ROE N/A
ROIC N/A
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LFMD Yearly ROA, ROE, ROICLFMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

1.3 Margins

LFMD's Gross Margin of 87.57% is amongst the best of the industry. LFMD outperforms 94.29% of its industry peers.
In the last couple of years the Gross Margin of LFMD has grown nicely.
LFMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
LFMD Yearly Profit, Operating, Gross MarginsLFMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

2

2. Health

2.1 Basic Checks

LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
LFMD has more shares outstanding than it did 5 years ago.
LFMD has a better debt/assets ratio than last year.
LFMD Yearly Shares OutstandingLFMD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LFMD Yearly Total Debt VS Total AssetsLFMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

LFMD has an Altman-Z score of 0.68. This is a bad value and indicates that LFMD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.68, LFMD is in line with its industry, outperforming 51.43% of the companies in the same industry.
The Debt to FCF ratio of LFMD is 2.31, which is a good value as it means it would take LFMD, 2.31 years of fcf income to pay off all of its debts.
LFMD's Debt to FCF ratio of 2.31 is fine compared to the rest of the industry. LFMD outperforms 77.14% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.31
Altman-Z 0.68
ROIC/WACCN/A
WACC10.2%
LFMD Yearly LT Debt VS Equity VS FCFLFMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

LFMD has a Current Ratio of 0.77. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.77, LFMD is doing worse than 80.00% of the companies in the same industry.
LFMD has a Quick Ratio of 0.77. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
LFMD's Quick ratio of 0.72 is on the low side compared to the rest of the industry. LFMD is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.72
LFMD Yearly Current Assets VS Current LiabilitesLFMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 70.00% over the past year.
Looking at the last year, LFMD shows a very strong growth in Revenue. The Revenue has grown by 37.74%.
Measured over the past years, LFMD shows a very strong growth in Revenue. The Revenue has been growing by 76.23% on average per year.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%

3.2 Future

Based on estimates for the next years, LFMD will show a very strong growth in Earnings Per Share. The EPS will grow by 40.83% on average per year.
The Revenue is expected to grow by 19.29% on average over the next years. This is quite good.
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5YN/A
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LFMD Yearly Revenue VS EstimatesLFMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
LFMD Yearly EPS VS EstimatesLFMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LFMD. In the last year negative earnings were reported.
LFMD is valuated quite expensively with a Price/Forward Earnings ratio of 25.84.
LFMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 71.43% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LFMD to the average of the S&P500 Index (23.23), we can say LFMD is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 25.84
LFMD Price Earnings VS Forward Price EarningsLFMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

LFMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 68.57% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LFMD indicates a somewhat cheap valuation: LFMD is cheaper than 65.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 41.34
EV/EBITDA 30.07
LFMD Per share dataLFMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMD's earnings are expected to grow with 40.83% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.23%
EPS Next 3Y40.83%

0

5. Dividend

5.1 Amount

No dividends for LFMD!.
Industry RankSector Rank
Dividend Yield N/A

LIFEMD INC

NASDAQ:LFMD (10/22/2025, 4:37:17 PM)

After market: 6.15 0 (0%)

6.15

-0.02 (-0.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners53.98%
Inst Owner Change0.11%
Ins Owners18.82%
Ins Owner Change2.51%
Market Cap277.00M
Revenue(TTM)245.56M
Net Income(TTM)-9034000
Analysts81.33
Price Target13.13 (113.5%)
Short Float %13.63%
Short Ratio2.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)0%
PT rev (3m)-8.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-89.82%
EPS NY rev (3m)-859.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.84
P/S 1.13
P/FCF 41.34
P/OCF 14.22
P/B N/A
P/tB N/A
EV/EBITDA 30.07
EPS(TTM)-0.21
EYN/A
EPS(NY)0.24
Fwd EY3.87%
FCF(TTM)0.15
FCFY2.42%
OCF(TTM)0.43
OCFY7.03%
SpS5.45
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.28%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.57%
FCFM 2.73%
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.31
Debt/EBITDA 0.41
Cap/Depr 120.74%
Cap/Sales 5.2%
Interest Coverage N/A
Cash Conversion 227.76%
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.72
Altman-Z 0.68
F-Score5
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y74.18%
EPS Next 2Y56.23%
EPS Next 3Y40.83%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year23.06%
Revenue Next 2Y20.2%
Revenue Next 3Y19.29%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.54%
EBIT Next 3Y69.78%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%